Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function

NCT02334488 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

329

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Everolimus
DRUG: Tacrolimus
DRUG: Mycophenolate sodium

Sponsor

Poitiers University Hospital